TY - JOUR
T1 - Parallel factor analysis of ovarian autofluorescence as a cancer diagnostic
AU - George, Ronie
AU - Michaelides, Michalis
AU - Brewer, Molly A.
AU - Utzinger, Urs
PY - 2012/4
Y1 - 2012/4
N2 - Background and Objectives Endogenous fluorescence from certain amino acids, structural proteins, and enzymatic co-factors in tissue is altered by carcinogenesis. We evaluate the potential of these changes in fluorescence to predict a diagnosis of malignancy and to estimate the risk of developing ovarian cancer. Study Design/Materials and Methods Ovarian biopsies were interrogated over 270-550nm excitation and fluorescence was collected from 290 to 700nm. Two hundred forty-nine measurements were performed on 49 IRB-consented patients undergoing oophorectomy. Data are analyzed using parallel factor analysis to determine excitation and emission spectra of the underlying fluorophores that contribute to the total detected fluorescence intensity. Results Using multivariate normal distribution fits and cross-validation techniques, sensitivity and specificity of 88% and 93%, respectively, are achieved when classifying malignant samples versus others, while 88% and 80%, respectively, are achieved when classifying normal post-menopausal patients as being either at high- or low-risk of developing ovarian cancer based on their personal and family history of cancer. Performance of classifying cancer increases when the normal group does not include benign neoplasm and endometriosis samples. Performance of high- versus low-risk classification decreases when normal samples include both pre- and post-menopausal women. Excitation over 270-400 and 380-560nm, respectively, have the best diagnostic performance for cancer detection and risk-status assessment. Conclusions Assessing the endogenous fluorescence could be useful in screening women at increased risk of developing ovarian cancer.
AB - Background and Objectives Endogenous fluorescence from certain amino acids, structural proteins, and enzymatic co-factors in tissue is altered by carcinogenesis. We evaluate the potential of these changes in fluorescence to predict a diagnosis of malignancy and to estimate the risk of developing ovarian cancer. Study Design/Materials and Methods Ovarian biopsies were interrogated over 270-550nm excitation and fluorescence was collected from 290 to 700nm. Two hundred forty-nine measurements were performed on 49 IRB-consented patients undergoing oophorectomy. Data are analyzed using parallel factor analysis to determine excitation and emission spectra of the underlying fluorophores that contribute to the total detected fluorescence intensity. Results Using multivariate normal distribution fits and cross-validation techniques, sensitivity and specificity of 88% and 93%, respectively, are achieved when classifying malignant samples versus others, while 88% and 80%, respectively, are achieved when classifying normal post-menopausal patients as being either at high- or low-risk of developing ovarian cancer based on their personal and family history of cancer. Performance of classifying cancer increases when the normal group does not include benign neoplasm and endometriosis samples. Performance of high- versus low-risk classification decreases when normal samples include both pre- and post-menopausal women. Excitation over 270-400 and 380-560nm, respectively, have the best diagnostic performance for cancer detection and risk-status assessment. Conclusions Assessing the endogenous fluorescence could be useful in screening women at increased risk of developing ovarian cancer.
KW - UVC-excitation
KW - endogenous fluorescence
KW - excitation emission matrix
KW - ovarian cancer risk-status
KW - tissue optical spectroscopy
UR - http://www.scopus.com/inward/record.url?scp=84859759688&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859759688&partnerID=8YFLogxK
U2 - 10.1002/lsm.22014
DO - 10.1002/lsm.22014
M3 - Article
C2 - 22407572
AN - SCOPUS:84859759688
SN - 0196-8092
VL - 44
SP - 282
EP - 295
JO - Lasers in Surgery and Medicine
JF - Lasers in Surgery and Medicine
IS - 4
ER -